Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Split Course Hyperfractionated Accelerated Radio-Chemotherapy (SCHARC) for patients with advanced head and neck cancer: Influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis

Figure 2

Kaplan Meier Analysis of survival probability. Comparison between patients who completed the SCHARC-scheme (n = 40, black line) and patients with modified therapy (n = 24, blue line). The Cox regression analysis showed a statistically significant difference between the groups (p = 0.01).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us